Tearlab's Tearlab Osmolarity System, which Invetech helped to design and develop, has won a Medical Design Excellence Award (MDEA).
The Tearlab Osmolarity System can quantitatively and objectively measure dry-eye disease in seconds.
Dry-eye disease is a chronic and progressive condition that if left untreated can lead to serious eye damage.
The Tearlab Osmolarity System reduces the complexity, cost and patient discomfort of conventional tear-testing technologies.
Tearlab achieves CLIA waiver status, reflecting its ease of use.
The product features a hand-held pen system that operates from as little as 50 nanolitres of tear samples, considerably less than current swab methods.
The pen is a smart collection device that minimises patient discomfort, avoids sample-dilution from reflex tearing and minimises sample evaporation to provide repeatable and accurate test results.
It houses miniaturised electronics and holds a disposable lab-on-a-chip, a joint development between Tearlab and Minifab.
A desktop reader converts the results generated from the pen in to a quantitative measurement.
The entire process from tear collection to results takes just seconds, giving an eye-care practitioner the opportunity to see more patients while improving the quality of care.
Already available in Europe, Tearlab is currently under FDA review in the US, prior to launch in this market.
